The BSPHO unites the recognized Belgian centres in paediatric haemato-oncology and their professionals to share expertise and knowledge to improve treatment and patient care in childhood cancer
.png?width=3072&format=webp)
The Council of Ministers approved an amendment to the Royal Decree on paediatric oncology which groups patients in a smaller number of reference centres and creates networks to organise parts of the treatment trajectory close to the patient's home.
The first BSPHO Scientific Meeting of 2024 brought together physicians and researchers to discuss paediatric haemato-oncology advancements.
In January 2024, the NORDIC trial launched and will evaluate Cerebellar Mutism Syndrome in children undergoing brain tumour surgery.
The Department of Pediatric Hemato-Oncology at the Queen Fabiola Children's University Hospital (HUDERF) is recruiting a Hemato-Oncology Clinical Studies Coordinator (CDI - 38H).
.png?width=3072&format=webp)
The 2nd BSPHO Scientific Meeting of 2024 will take place in September.
For the 3rd year in a row, KickCancer will organise their patients’ conference in concertation with BSPHO.
Join us at the Young BSPHO symposium, showcasing diverse perspectives in pediatric oncology through presentations and interactive Q&A sessions.
